Evidence map›Paper›PMID 24162659›Full record

ReviewCell death and differentiation2014

The rheostat in the membrane: BCL-2 family proteins and apoptosis.

N Volkmann, F M Marassi, D D Newmeyer, D Hanein

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell death and differentiation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 1 synthesis or guideline pooled it, 230 citations in OpenAlex.

  1. Pooled it
  2. Prognostic model construction and drug prediction in colorectal cancer using mitochondrial programmed cell death-related genes.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Review
  5. Advances inMicroorganisms · 2025
    Review
  6. The Role of Functional Polymorphisms of ApoptoticIranian journal of medical sciences · 2025
    Article
  7. Article
  8. Article
  9. International journal of fertility & sterility · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

N VolkmannBioinformatics and Systems Biology Program, Sanford Burnham Medical Research Institute, La Jolla, CA 92037, USA.
F M MarassiApoptosis and Cell Death Research Program, Sanford Burnham Medical Research Institute, La Jolla, CA 92037, USA.
D D NewmeyerDivision of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
D HaneinBioinformatics and Systems Biology Program, Sanford Burnham Medical Research Institute, La Jolla, CA 92037, USA.
Sanford Burnham Prebys Medical Discovery Institute · USLa Jolla Institute for Immunology · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Target IdentificationP01AI074805 · NIAID · FLORIDA STATE UNIVERSITY · PI CROSS, TIMOTHY A · 2009 to 2013
$8.7M
Ultrastructural Basis of Mechanotransduction in Matrix AdhesionsP01GM098412 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI GROISMAN, ALEX · 2011 to 2015
$8.0M
MITOCHONDRIAL FUNCTION IN APOPTOSISR01GM062289 · NIGMS · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI NEWMEYER, DONALD DAVID · 2001 to 2013
$4.3M
Host recognition by pathogenic yersiniaeR01GM100265 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MARASSI, FRANCESCA M · 2012 to 2015
$1.7M
NCI NIH HHS P30 CA030199NIAID NIH HHS P01 AI074805NIAID NIH HHS P01-AI074805NIGMS NIH HHS P01 GM098412NIGMS NIH HHS P01-GM098412NIGMS NIH HHS R01 GM062289NIGMS NIH HHS R01 GM100265NIGMS NIH HHS R01-GM100265NIGMS NIH HHS R01-GM62289
6 · The paper itself

Abstract

Apoptosis, a mechanism for programmed cell death, has key roles in human health and disease. Many signals for cellular life and death are regulated by the BCL-2 family proteins and converge at mitochondria, where cell fate is ultimately decided. The BCL-2 family includes both pro-life (e.g. BCL-XL) and pro-death (e.g. BAX, BAK) proteins. Previously, it was thought that a balance between these opposing proteins, like a simple 'rheostat', could control the sensitivity of cells to apoptotic stresses. Later, this rheostat concept had to be extended, when it became clear that BCL-2 family proteins regulate each other through a complex network of bimolecular interactions, some transient and some relatively stable. Now, studies have shown that the apoptotic circuitry is even more sophisticated, in that BCL-2 family interactions are spatially dynamic, even in nonapoptotic cells. For example, BAX and BCL-XL can shuttle between the cytoplasm and the mitochondrial outer membrane (MOM). Upstream signaling pathways can regulate the cytoplasmic-MOM equilibrium of BAX and thereby adjust the sensitivity of cells to apoptotic stimuli. Thus, we can view the MOM as the central locale of a dynamic life-death rheostat. BAX invariably forms extensive homo-oligomers after activation in membranes. However, recent studies, showing that activated BAX monomers determine the kinetics of MOM permeabilization (MOMP), perturb the lipid bilayer and form nanometer size pores, pose questions about the role of the oligomerization. Other lingering questions concern the molecular mechanisms of BAX redistribution between MOM and cytoplasm and the details of BAX/BAK-membrane assemblies. Future studies need to delineate how BCL-2 family proteins regulate MOMP, in concert with auxiliary MOM proteins, in a dynamic membrane environment. Technologies aimed at elucidating the structure and function of the full-length proteins in membranes are needed to illuminate some of these critical issues.

Indexed as

ApoptosisCytoplasmHumansMitochondrial MembranesProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-bcl-2

Identifiers

PMID24162659
PMCPMC3890954
OpenAlexW1975670490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.